Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check41 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics, multiple myeloma, vaccines, and clinical trials.SummaryDifference0.5%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new resources added related to multiple myeloma, including links to clinical trials, treatment information, and genetic resources.SummaryDifference4%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.